netFormulary NHS
Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
 Search
 Formulary Chapter 1: Gastro-intestinal system - Full Chapter
01.03  Expand sub section  Antisecretory drugs and mucosal protectants
01.03  Expand sub section  Helicobacter pylori infection
 note 

Please see below for the reccomended regimens for Helicobacter pylori eradication.

If either regimen (1or 2) is not suitable for the patient please refer to BNF for alternative options. The regimen with the lowest aquisition cost should be used.

Regimen 3 may consist of a combination of the drugs listed. Doses,duration and any further information will be provided by a gastroenterologist 

Regimen 1
Formulary
Blue
Drug Dose Duration
Omeprazole 20mg BD 7 days
Amoxicillin 1g BD
Clarithromycin 500mg BD

Interactions with clarithromycin

Inhibits metabolism of theophylline; consider reducing total daily dose of theophylline by up to 50%

Increased risk of myopathy with statins; avoid concomitant use

 
   
Regimen 2
Formulary
Blue

Penicillin allergic patients

Drug Dose Duration
Omeprazole 20mg BD 7 days
Clarithromycin 250mg BD
Metronidazole 400mg BD

 

Interactions with clarithromycin

Inhibits metabolism of theophylline; consider reducing total daily dose of theophylline by up to 50%

Increased risk of myopathy with statins; avoid concomitant use

 
   
Regimen 3
Formulary
Green

Gastro recommended regimen 

Regimen 3 may consist of a combination of the drugs listed. Doses,duration and any further information will be provided by a gastroenterologist

Drug Dose Duration
Tinidazole To be provided by gastroenterology To be provided by gastroenterology
Tetracycline
Levofloxacin
Colloidal bismuth subcitrate (Gastrodenol)

 

 
   
01.03.01  Expand sub section  H2-receptor antagonists
01.03.03  Expand sub section  Chelates and complexes
01.03.04  Expand sub section  Prostaglandin analogues to top
01.03.05  Expand sub section  Proton pump inhibitors (PPIs)
 note 

MHRA: Very low risk of subacute cutaneous lupus erythematosus

MHRA: Increased risk of fracture with long term use

MHRA: Hypomagnesaemia with long term use

 ....
 Non Formulary Items
diabact UBT

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Helicobacter Test Hp-Olus

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Helicobacter Test INFAI

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Pylobactell

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Blue

For routine prescribing in primary and secondary care.   

Green

Initiated (if clinically urgent) or advised (if non-urgent) by specialist in secondary care, prescribing can be continued in primary care.   

Amber

Shared care  

Red Hospital

Hospital only  

Double Red

There should be no prescribing of these drugs  

Mixed

The traffic light of the drug is dependant on the indication. Please see individual drug entry for details  

netFormulary